Patent directory · USPTO A61K / A61P
Patents matching “LTD.”
1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12325703
Fused ring compound as FGFR and VEGFR dual inhibitor
granted -
US 12318457
Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
granted -
US 12319748
Antibody binding to human HER2 and preparation method and use thereof
granted -
US 12318362
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12304898
Quinolyl-containing compound and pharmaceutical composition, and use thereof
granted -
US 12295394
Water-soluble additive composition
granted -
US 12290588
Peptide having activity of improving skin condition and use thereof
granted -
US 12279630
Treatment and prevention of seed allergies
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12263145
Methods of administering solriamfetol to lactating women
granted -
US 12258317
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
granted -
US 12251417
Antimicrobial compounds from the genus Delftia
granted -
US 12240914
Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof
granted -
US 12233092
MSC-NTF specific exosomes and use thereof
granted -
US 12227581
Anti-BCMA single domain antibodies and application thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12213990
A3 adenosine receptor ligand for use for achieving a fat loss effect
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12209085
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12201601
Treatment for obesity
granted -
US 12201701
Vegetable oil-derived contrast agent with high stability and preparation method thereof
granted -
US 12194079
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
granted